Bml Capital Management, LLC Portfolio Holdings

Bml Capital Management, LLC

  • $109 Billion
  • Q3 2025

Bml Capital Management, LLC has filed its 13F form on November 10, 2025 for Q3 2025 where it was disclosed a total value porftolio of $109 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Aclaris Therapeutics, Inc. with a value of $27.1B, Atea Pharmaceuticals, Inc. with a value of $21.7B, Adverum Biotechnologies Inc with a value of $13.9B, Instil Bio Inc with a value of $11.5B, and Oramed Pharmaceuticals Inc. with a value of $8.36B.

Examining the 13F form we can see an decrease of $23B in the current position value, from $132B to 109B.

Bml Capital Management, LLC is based out at Zionsville, IN

Below you can find more details about Bml Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $109 Billion
Healthcare: $68 Billion
Consumer Defensive: $1.42 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$42.8M
$3.07 Billion 2.81% of portfolio
1,970,610
Q2 2025 Added 0.51%

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $109 Billion
  • Prior Value $132 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 10, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 6 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email